BioCryst Pharmaceuticals
BCRX
#4497
Rank
NZ$4.00 B
Marketcap
NZ$15.95
Share price
-1.57%
Change (1 day)
32.96%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$0.74 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.74 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.75 B-47.16%
2024-12-31NZ$1.43 B9.9%
2023-12-31NZ$1.30 B11.73%
2022-12-31NZ$1.16 B34.46%
2021-12-31NZ$0.86 B124.21%
2020-12-31NZ$0.38 B208.18%
2019-12-31NZ$0.12 B36.38%
2018-12-31NZ$92.16 M19.62%
2017-12-31NZ$77.05 M-0.65%
2016-12-31NZ$77.55 M75.89%
2015-12-31NZ$44.09 M15.16%
2014-12-31NZ$38.28 M4.88%
2013-12-31NZ$36.5 M0.11%
2012-12-31NZ$36.46 M-5.13%
2011-12-31NZ$38.43 M
2000-12-31NZ$0.02 M
1997-12-31NZ$0.17 M-59.42%
1996-12-31NZ$0.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
NZ$42.27 B 5,581.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$40.46 B 5,337.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$1.76 B 136.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.16 B 57.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.42 B-43.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.96 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$2.54 M-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$15.91 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.12 B 51.09%๐Ÿ‡บ๐Ÿ‡ธ USA